Hoogerbrugge PM - Search Results

1

Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.

Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ, O'Meara A, Cornu G, Souillet G, Frappaz D, et al. Hoogerbrugge PM, et al. Lancet. 1995 Jun 3;345(8962):1398-402. doi: 10.1016/s0140-6736(95)92597-x. Lancet. 1995. PMID: 7760610

2

State of the art review. Bone marrow transplantation treatment for storage diseases. Keystone. January 23, 1992.

Krivit W, Shapiro E, Hoogerbrugge PM, Moser HW. Krivit W, et al. Among authors: hoogerbrugge pm. Bone Marrow Transplant. 1992;10 Suppl 1:87-96. Bone Marrow Transplant. 1992. PMID: 1521098 Review. No abstract available.

3

Bone marrow transplantation for metabolic diseases with severe neurological symptoms.

Hoogerbrugge PM, Brouwer OF, Fischer A. Hoogerbrugge PM, et al. Bone Marrow Transplant. 1991;7 Suppl 2:71. Bone Marrow Transplant. 1991. PMID: 1908728 No abstract available.

4

Alleviation of neurologic symptoms after bone marrow transplantation in twitcher mice.

Hoogerbrugge PM, Poorthuis BJ, Wagemaker G, van Bekkum DW, Suzuki K. Hoogerbrugge PM, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):2980-1. Transplant Proc. 1989. PMID: 2650408 No abstract available.

5

Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation.

Hoogerbrugge PM, Suzuki K, Suzuki K, Poorthuis BJ, Kobayashi T, Wagemaker G, van Bekkum DW. Hoogerbrugge PM, et al. Science. 1988 Feb 26;239(4843):1035-8. doi: 10.1126/science.3278379. Science. 1988. PMID: 3278379

6

Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse.

Hoogerbrugge PM, Poorthuis BJ, Romme AE, van de Kamp JJ, Wagemaker G, van Bekkum DW. Hoogerbrugge PM, et al. J Clin Invest. 1988 Jun;81(6):1790-4. doi: 10.1172/JCI113521. J Clin Invest. 1988. PMID: 3290253 Free PMC article.

7

Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.

Hoogerbrugge PM, Gerritsen EJ, vd Does-van den Berg A, vd Berg H, Zwinderman AH, Hermans J, Vossen JM. Hoogerbrugge PM, et al. Bone Marrow Transplant. 1995 Feb;15(2):255-9. Bone Marrow Transplant. 1995. PMID: 7773215

8

[Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].

Maaswinkel-Mooij PD, Poorthuis BJ, Hoogerbrugge PM, Brouwer OF, Vossen JM. Maaswinkel-Mooij PD, et al. Among authors: hoogerbrugge pm. Ned Tijdschr Geneeskd. 1998 Jan 24;142(4):169-74. Ned Tijdschr Geneeskd. 1998. PMID: 9557021 Review. Dutch.

9

Bone marrow transplantation and gene therapy for lysosomal storage diseases.

Hoogerbrugge PM, Valerio D. Hoogerbrugge PM, et al. Bone Marrow Transplant. 1998 Apr;21 Suppl 2:S34-6. Bone Marrow Transplant. 1998. PMID: 9630322 Review.

10

[Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].

van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM. van Steekelenburg M, et al. Among authors: hoogerbrugge pm. Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1542-6. Ned Tijdschr Geneeskd. 2002. PMID: 12212502 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters